Stoxline.com

Stock Symbol:   

Stoxline Mobile
Home  |  Stock Charts  |  Showcases  |  Stock Ranks  |  Options  |  ETFs  |  Educations  |  Forex Crypto

Agile Therap (AGRX)

2.88   0.08 (2.86%) 09-27 22:12
Open: 2.82 Pre. Close: 2.8
High: 2.89 Low: 2.78
Volume: 977,874 Market Cap: 251M
Agile Therapeutics, Inc. is a healthcare company, which engages in the development and commercialization of transdermal patch. The company is headquartered in Princeton, New Jersey and currently employs 13 full-time employees. The firm is focused in the development and commercialization of prescription contraceptive products. The firm has developed a transdermal patch technology, called Skinfusion. The firm's lead product candidate is Twirla, also known as AG200-15, is a combined hormonal contraceptive (CHC) patch. In addition to Twirla, the Company is developing a pipeline of other new transdermal contraceptive products, including AG200-ER, which is a regimen designed to allow a woman to extend the length of her cycle; AG200-SP, which is a regimen designed to provide a shortened hormone-free interval, and AG890, which is a progestin-only contraceptive patch intended for use by women who are unable or unwilling to take estrogen. Each of its product candidates utilizes its Skinfusion technology designed to deliver contraceptive-levels of hormones to the blood stream through the skin over a seven-day period.

Stock Price Prediction

Update at 5:00pm EST
If tomorrow: Open lower Open higher
High: 2.897 - 2.916 2.916 - 2.933
Low: 2.733 - 2.757 2.757 - 2.779
Close: 2.842 - 2.881 2.881 - 2.916

Technical analysis

as of: 2020-09-25 4:27:07 PM
Overall:       
Stoxline posted a NEUTRAL today, upgraded from lower rating. Current trend continues, but could change at anytime. It is not a good time to buy or sell.
Target: Six months: 4.00     One year: 4.54
Support: Support1: 2.67    Support2: 2.22
Resistance: Resistance1: 3.42    Resistance2: 3.89
Pivot: 3.34
Moving Average: MA(5): 3.01     MA(20): 3.26
MA(100): 2.84     MA(250): 2.51
MACD: MACD(12,26): 0.04     Signal(9): 0.14
Stochastic oscillator: %K(14,3): 14.48     %D(3): 24.23
RSI: RSI(14): 42.26
52-week: High: 4.76  Low: 0.35  Change(%): 143.0
Average Vol(K): 3-Month: 137403  10-Days: 167796

Price, moving averages and Bollinger Bands

Price and moving averages has closed below its Short term moving average. Short term moving average is currently above mid-term; AND above long term moving averages. From the relationship between price and moving averages; we can see that: This stock is NEUTRAL in short-term; and BULLISH in mid-long term.
AGRX has closed above bottom band by 19.1%. Bollinger Bands are 150.8% wider than normal. The large width of the bands suggest high volatility as compared to AGRX's normal range. The bands have been in this wide range for 10 bars. This is a sign that the current trend might continue.

Headline News

Tue, 11 Aug 2020
Agile Therapeutics Reports Second Quarter 2020 Financial Results - GlobeNewswire

Tue, 21 Jul 2020
Agile Therapeutics to Host Second Quarter 2020 Financial Results and Business Update Conference Call on Tuesday, August 11, 2020 - GlobeNewswire

Tue, 16 Jun 2020
Agile Therapeutics to Join Russell 3000® and 2000® Indexes - GlobeNewswire

Mon, 11 May 2020
Agile Therapeutics to Participate in Virtual Fireside Chat as part of the 2020 RBC Capital Markets Global Healthcare Conference on Wednesday, May 20, 2020 - GlobeNewswire

Tue, 05 May 2020
Agile Therapeutics Reports First Quarter 2020 Financial Results - GlobeNewswire

Wed, 22 Apr 2020
Agile Therapeutics Announces Changes to its Board of Directors - GlobeNewswire

Financial Analysis

Growth
Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing.
Profitability
Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs.
Solvency
Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry.
Efficiency n/a
Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not.
Price to Book Value: Outperform Discounted cash flow: Outperform
Return on Assets: Underperform Price to Earnings: Underperform
Return on Equity: Underperform Debt to Equity: Neutral
Free Technical Analysis Charts

Stock Basics & Statistics

Exchange:  NASDAQ
Sector:  Healthcare
Industry:  Drug Manufacturers General Specialty & Generic
Shares Out. (M) 87
Shares Float (M) 65
% Held by Insiders 0.69
% Held by Institutions 38.86
Shares Short (K) 4,650
Shares Short P. Month (K) 4,370

Stock Financials

EPS -0.416
EPS Est This Year -1.020
EPS Est Next Year -0.980
Book Value (p.s.) 0.930
Profit Margin
Operating Margin
Return on Assets (ttm) -27.6
Return on Equity (ttm) -56.2
Qtrly Rev. Growth
Gross Profit (p.s.)
Sales Per Share
EBITDA (p.s.) -0.322
Qtrly Earnings Growth
Operating Cash Flow (M) -23
Levered Free Cash Flow (M) -13

Stock Valuations

PE Ratio -6.92
PEG Ratio
Price to Book value 3.10
Price to Sales
Price to Cash Flow -10.93

Stock Dividends

Dividend
Forward Dividend
Dividend Yield
Dividend Pay Date Invalid DateTime.
Ex-Dividend Date Invalid DateTime.
7 Binary Options
Your Ad Here
android_stock_chart
Stock Chart
stoxline_lite
Stoxline Lite
stoxline_pro
Stoxline Pro
Option_Calculator
Option Calculator
(c) 2006-2020 Stoxline.com | Contact us           
Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither Stoxline.com nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the Stoxline.com web site, a user agrees not to redistribute the information found therein.